AP136F
Goat Anti-Rat IgG Antibody, FITC conjugate
26 mg/mL, Chemicon®
Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
About This Item
Code UNSPSC :
12352203
eCl@ss :
32160702
Nomenclature NACRES :
NA.46
Produits recommandés
Source biologique
goat
Niveau de qualité
Conjugué
FITC conjugate
Forme d'anticorps
F(ab′)2 fragment of affinity isolated antibody
Type de produit anticorps
secondary antibodies
Clone
polyclonal
Espèces réactives
rat
Fabricant/nom de marque
Chemicon®
Concentration
26 mg/mL
Technique(s)
immunofluorescence: suitable
Conditions d'expédition
wet ice
Modification post-traductionnelle de la cible
unmodified
Spécificité
Reacts with Rat IgG gamma chain, as well as the light chains from all rat immunoglobulin classes. Monospecific on IEP against whole rat serum. Single band on IEP at a concentration of 10 mg/mL when run against rabbit anti goat whole serum.
FLUOROPHORE/ PROTEIN:
Approximately 12 mg/mg.
FLUOROPHORE/ PROTEIN:
Approximately 12 mg/mg.
Immunogène
Highly purified Rat IgG isolated from pooled normal rat serum.
Application
Goat anti-Rat IgG Antibody, FITC conjugate is an antibody against Rat IgG for use in IF.
Research Category
Secondary & Control Antibodies
Secondary & Control Antibodies
Research Sub Category
Whole Immunoglobulin Secondary Antibodies
Whole Immunoglobulin Secondary Antibodies
Stockage et stabilité
When protected from light, the lyophilized antibody conjugate is stable at 2-8°C.
DO NOT FREEZE.
DO NOT FREEZE.
Informations légales
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Clause de non-responsabilité
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Vous ne trouvez pas le bon produit ?
Essayez notre Outil de sélection de produits.
Mentions de danger
Conseils de prudence
Classification des risques
Aquatic Chronic 3
Code de la classe de stockage
11 - Combustible Solids
Classe de danger pour l'eau (WGK)
WGK 3
Certificats d'analyse (COA)
Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".
Déjà en possession de ce produit ?
Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.
Zheng Liu et al.
Redox biology, 52, 102305-102305 (2022-04-04)
Hepatocellular cell death and macrophage proinflammatory activation contribute to the pathology of various liver diseases, during which XBP1 plays an important role. However, the function and mechanism of XBP1 in thioacetamide (TAA)-induced acute liver injury (ALI) remains unknown. Here, we
Gioia Marino et al.
Science advances, 9(28), eadh1403-eadh1403 (2023-07-14)
Intensive physical activity improves motor functions in patients with Parkinson's disease (PD) at early stages. However, the mechanisms underlying the beneficial effects of exercise on PD-associated neuronal alterations have not been fully clarified yet. Here, we tested the hypothesis that
Shintaro Nakao et al.
The American journal of pathology, 171(3), 1058-1065 (2007-08-11)
Dexamethasone, a synthetic corticosteroid, is widely used as a potent anti-inflammatory drug in various diseases including corneal angiogenesis. However, dexamethasone's impact on interleukin (IL)-1beta-dependent inflammatory angiogenesis is unknown. Here, we show that dexamethasone inhibits IL-1beta-induced neovascularization and the expression of
Alessandro Tozzi et al.
Brain : a journal of neurology, 144(11), 3477-3491 (2021-07-24)
Misfolding and aggregation of α-synuclein are specific features of Parkinson's disease and other neurodegenerative diseases defined as synucleinopathies. Parkinson's disease progression has been correlated with the formation and extracellular release of α-synuclein aggregates, as well as with their spread from
J K L Woodward et al.
Eye (London, England), 19(3), 342-348 (2004-07-20)
To establish if invasive and noninvasive uveal melanomas have differences in expression of adhesion molecules, and whether their adhesive interactions with the extracellular matrix (ECM) and endothelium vary. Cells from an invasive and noninvasive uveal melanoma cell line and hepatic
Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..
Contacter notre Service technique